for reference tracking and overall stability, and the proposed method has less overshoot, shorter settling time and is more robust to disturbances.
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Effect Site
The PK model provides the propofol plasma concentration from a given dose of propofol injected to the patient.
where PK is expressed as:
s + P3 where C p et) is the drug concentration expressed in microgram per milliliter (propofol), PI and pz in the above fonnula would refer to the rate constant of the distribution phase and P3 is the rate constant of the elimination phase.
where uCs) is the control input.
PD is expressed as:
where keo is the inverse of the effect-site compartment time constant and ECso is the half-maximal effective concentration.
The Hill curve is represented by the following equation:
Eo denotes the baseline value (awake state) and by convention a value of 100 is assigned. Emax denotes the maximum effect achieved by the drug. Ce is the drug effect-site concentration, ECso is the drug concentration at half maximum effect and represents the patient sensitivity to the drug, and y detennines the steepness of the curve.
The patient's PK and PD models are used to predict the BIS output as a result of drug infusion. The generalized PK PD model for propofol is shown in Fig. 2 . 
III. MATERIALS AND METHODS
The total time delay can be categorized into two parts.
The fIrst is related to the instrumentation parts, representing the time delays at the instrument devices and the second are related to the dynamic response of the patient (non instrumentation delay).
A. Time-Delay estimation
During surgery, when the patient arrives at the ICU, the desired BIS target is 50 and must remain between 40 and 60 957 for a good sedation level. At around 50 BIS can be approximated linearly by a line, using this relation, as in
where a represents the slope of the linear approximation and b is a constant.
The real values of the parameters for the selected 12 patient sets are given in Table 1 y es) R(s)
In Fig. 4 , the part of with the dotted line is the SPC and its transfer function obtained below: Y e s) Gc (s) Gp (s)
where G p (s) is the patient model and consist of two parts, PK and PD [1].
Thus, the system will present the same closed-loop performance without the time delay, only with the pure input time delay t p . The Smith predictor Controller is purposed when DoA delays are significant as t p = tm.
V. SIMULATION AND RESULTS
The study was performed on a data set of 12 patients from The delay signal is then added to the feedback signal. As a result, the controller based on a delay-free model, which results in added stability in the control loop that can be further used to increase the controller bandwidth.
While the inherent limitation of a delayed system is still present, the increased control bandwidth usually results in improved performances. As far as the implementation of the SPC is concerned, the nominal time delay is now replaced by the identified time delay.
When a patient has significant time delay, it is quite common to augment the controller with a Smith predictor, a construction that removes the delay term from the characteristics polynomial of the closed loop.
(/) iii [I]
[2]
[3]
[4]
[5]
[6] [7] [8]
[9]
